{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:18:23Z","timestamp":1791919103706,"version":"4.3.4"},"reference-count":286,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.cyto.2022.155962","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T19:38:23Z","timestamp":1658000303000},"page":"155962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Exploring the management approaches of cytokines including viral infection and neuroinflammation for neurological disorders"],"prefix":"10.1016","volume":"157","author":[{"given":"Md.","family":"Mominur Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Afsana Mim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mst.","family":"Afroza Alam Tumpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.","family":"Taslim Sarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muniruddin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badrah S.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Hafeez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2206-7236","authenticated-orcid":false,"given":"Athanasios","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Perveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam","family":"Md Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b0005","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0952-7915(93)90139-J","article-title":"Cytokine dysregulation as a mechanism of graft versus host disease","volume":"5","author":"Ferrara","year":"1993","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cyto.2022.155962_b0010","volume":"vol. 138","author":"Thepmankorn","year":"2021","journal-title":"Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1471-4906(02)02195-6","article-title":"Cytokines as a link between innate and adaptive antitumor immunity","volume":"23","author":"Belardelli","year":"2002","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b0020","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s13311-016-0455-1","article-title":"Cytokine therapies in neurological disease","volume":"13","author":"Azodi","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.cyto.2022.155962_b0025","first-page":"79","volume":"13","author":"Sugaya","year":"2002","journal-title":"Influenza-associated encephalopathy in Japan"},{"issue":"42","key":"10.1016\/j.cyto.2022.155962_b0030","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1073\/pnas.0405954101","article-title":"Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox","volume":"101","author":"Jahrling","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cyto.2022.155962_b0035","article-title":"Human infection by avian influenza A H5N1","author":"Yuen","year":"2005","journal-title":"Hong Kong Medical Journal"},{"issue":"20","key":"10.1016\/j.cyto.2022.155962_b0040","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1212\/01.wnl.0000435556.21319.e4","article-title":"Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity","volume":"81","author":"Jack","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"The Lancet Neurology"},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b0050","first-page":"804","article-title":"\u201cApplications of Phyto-Nanotechnology for the Treatment of","volume":"15","author":"Bhattacharya","year":"2022","journal-title":"Neurodegenerative Disorders,\u201c"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0055","first-page":"147","article-title":"\u201cStem Cell Transplantation Therapy and Neurological Disorders","volume":"11","author":"Rahman","year":"2022","journal-title":"Current Status and Future Perspectives,\u201c"},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b0060","first-page":"216","article-title":"\u201cHutchinson-Gilford Progeria Syndrome: An Overview of the Molecular Mechanism","volume":"21","author":"Rahman","year":"2021","journal-title":"Pathophysiology and Therapeutic Approach,\u201c"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.cyto.2022.155962_b0070","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2022.155962_b0075","doi-asserted-by":"crossref","unstructured":"M. Rahman et al., \u201cCitrus limon L.(lemon) seed extract shows neuro-modulatory activity in an in vivo thiopental-sodium sleep model by reducing the sleep onset and enhancing the sleep duration,\u201d vol. 21, no. 1, 2022.","DOI":"10.31083\/j.jin2101042"},{"issue":"8","key":"10.1016\/j.cyto.2022.155962_b0080","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","article-title":"Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study","volume":"11","author":"Clark","year":"2012","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-016-0399-z","article-title":"Post-mortem histopathology underlying \u03b2-amyloid PET imaging following flutemetamol F 18 injection","volume":"4","author":"Ikonomovic","year":"2016","journal-title":"Acta neuropathologica communications"},{"key":"10.1016\/j.cyto.2022.155962_b0090","first-page":"517","volume":"39","author":"Chousterman","year":"2017","journal-title":"Cytokine storm and sepsis disease pathogenesis"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0095","first-page":"1","volume":"17","author":"Khadke","year":"2020","journal-title":"Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents"},{"key":"10.1016\/j.cyto.2022.155962_b0100","doi-asserted-by":"crossref","unstructured":"L. S. Nidadavolu and J. D. J. T. J. o. G. S. A. Walston, \u201cUnderlying vulnerabilities to the cytokine storm and adverse COVID-19 outcomes in the aging immune system,\u201d vol. 76, no. 3, pp. e13-e18, 2021.","DOI":"10.1093\/gerona\/glaa209"},{"key":"10.1016\/j.cyto.2022.155962_b0105","doi-asserted-by":"crossref","unstructured":"I. McInnes, \u201cCytokines in Firestein GS, et al (Ed.) Kelley\u2019s Textbook of Rheumatology.(367-377),\u201d ed: Philadelphia, PA: Elsevier, 2013.","DOI":"10.1016\/B978-1-4160-3285-4.10023-3"},{"issue":"5214","key":"10.1016\/j.cyto.2022.155962_b0110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/224038a0","article-title":"\u201cLymphokines\u201d: Non-antibody mediators of cellular immunity generated by lymphocyte activation","volume":"224","author":"Dumonde","year":"1969","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cyto.2022.155962_b0115","first-page":"2563","article-title":"\u201cCytokines and chemokines: At the crossroads of cell signalling and inflammatory disease,\u201d Biochimica et Biophysica Acta (BBA)-Molecular","volume":"1843","author":"Turner","year":"2014","journal-title":"Cell Res."},{"issue":"9","key":"10.1016\/j.cyto.2022.155962_b0120","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/clinchem\/30.9.1539","article-title":"Lymphokines and monokines as regulators of human lymphoproliferation","volume":"30","author":"Kouttab","year":"1984","journal-title":"Clin. Chem."},{"issue":"9","key":"10.1016\/j.cyto.2022.155962_b0125","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","article-title":"An endotoxin-induced serum factor that causes necrosis of tumors","volume":"72","author":"Carswell","year":"1975","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b0130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/jir.1987.7.429","article-title":"Virus interference. I. The interferon","volume":"7","author":"Isaacs","year":"1987","journal-title":"J. Interferon Res."},{"key":"10.1016\/j.cyto.2022.155962_b0135","doi-asserted-by":"crossref","unstructured":"A. G. HOVANESSIAN, C. LA BONNARDIERE, and E. FALCOFF, \u201cAction of Murine \u03b3 (Immune) interferon on \u03b2 (Fibroblast)-Interferon Resistant L 1210 and Embryonal Carcinoma Cells,\u201d Journal of interferon research, vol. 1, no. 1, pp. 125-135, 1980.","DOI":"10.1089\/jir.1980.1.125"},{"issue":"3792","key":"10.1016\/j.cyto.2022.155962_b0140","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1126\/science.157.3792.1060","article-title":"Cytotoxic effect of lymphocyte-antigen interaction in delayed hypersensitivity","volume":"157","author":"Ruddle","year":"1967","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.cyto.2022.155962_b0145","first-page":"2842","article-title":"Transforming growth factor production by chemically transformed cells","volume":"41","author":"Moses","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2022.155962_b0150","first-page":"31","article-title":"\u201cClinical features of cytokine storm syndrome,\u201d in Cytokine storm syndrome","author":"Shimizu","year":"2019","journal-title":"Springer"},{"key":"10.1016\/j.cyto.2022.155962_b0155","first-page":"505","volume":"39","author":"Clark","year":"2017","journal-title":"The meteorology of cytokine storms, and the clinical usefulness of this knowledge"},{"issue":"7","key":"10.1016\/j.cyto.2022.155962_b0160","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2174\/1570159X15666170313122937","article-title":"The infectious etiology of Alzheimer's disease","volume":"15","author":"Sochocka","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"7","key":"10.1016\/j.cyto.2022.155962_b0165","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.cyto.2022.155962_b0170","volume":"vol. 2022","author":"Rahman","year":"2022","journal-title":"Multifunctional Therapeutic Approach of Nanomedicines against Inflammation in Cancer and Aging"},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b0175","first-page":"759","volume":"14","author":"Mitra","year":"2022","journal-title":"Hormonal therapy for gynecological cancers: how far has science progressed toward clinical applications?"},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b0180","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.0b013e3181aebd43","article-title":"Autonomic-mediated immunomodulation and potential clinical relevance","volume":"73","author":"Benarroch","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-11-1","article-title":"The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial","volume":"11","author":"Singh","year":"2014","journal-title":"Journal of neuroinflammation"},{"issue":"11","key":"10.1016\/j.cyto.2022.155962_b0190","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/STROKEAHA.110.579508","article-title":"AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke","volume":"41","author":"Sch\u00e4bitz","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.cyto.2022.155962_b0195","unstructured":"W.-Y. Wang, M.-S. Tan, J.-T. Yu, and L. Tan, \u201cRole of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease,\u201d Annals of translational medicine, vol. 3, no. 10, 2015."},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/01.wnl.0000333251.36681.a5","article-title":"A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis","volume":"72","author":"Mitchell","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2022.155962_b0205","first-page":"1","article-title":"Detection and Prediction of Incident Alzheimer Dementia over a 10-Year or Longer Medical History: A Population-Based Study in Primary Care","author":"Grande","year":"2020","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.cyto.2022.155962_b0210","unstructured":"D. Kempuraj et al., \u201cNeuroinflammation induces neurodegeneration,\u201d Journal of neurology, neurosurgery and spine, vol. 1, no. 1, 2016."},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b0215","first-page":"918","volume":"140","author":"Glass","year":"2010","journal-title":"Mechanisms underlying inflammation in neurodegeneration"},{"issue":"11","key":"10.1016\/j.cyto.2022.155962_b0220","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/biomedicines8110446","article-title":"Therapeutic Potential of Porcine Liver Decomposition Product: New Insights and Perspectives for Microglia-Mediated Neuroinflammation in Neurodegenerative Diseases","volume":"8","author":"Tsukahara","year":"2020","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b0225","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1620\/tjem.174.295","article-title":"Inflammatory response in Alzheimer's disease","volume":"174","author":"Akiyama","year":"1994","journal-title":"The Tohoku journal of experimental medicine"},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b0230","first-page":"1713","article-title":"\u201cThe Multifunctional Role of Herbal Products in the Management of Diabetes and Obesity","volume":"27","author":"Rahman","year":"2022","journal-title":"A Comprehensive Review,\u201c"},{"key":"10.1016\/j.cyto.2022.155962_b0235","first-page":"1","article-title":"The effects of glial cells inhibition on spatial reference, reversal and working memory deficits in a rat model of traumatic brain injury (TBI)","author":"Rezagholizadeh","year":"2020","journal-title":"Int. J. Neurosci."},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nri.2016.123","article-title":"Cytokine networks in neuroinflammation","volume":"17","author":"Becher","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"6048","key":"10.1016\/j.cyto.2022.155962_b0245","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1126\/science.1202529","article-title":"Synaptic pruning by microglia is necessary for normal brain development","volume":"333","author":"Paolicelli","year":"2011","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b0250","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2047-9158-1-9","article-title":"The changing phenotype of microglia from homeostasis to disease","volume":"1","author":"Luo","year":"2012","journal-title":"Translational neurodegeneration"},{"key":"10.1016\/j.cyto.2022.155962_b0260","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fncel.2018.00072","article-title":"An inflammation-centric view of neurological disease: beyond the neuron","volume":"12","author":"Skaper","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"9","key":"10.1016\/j.cyto.2022.155962_b0265","first-page":"1076","article-title":"\u201cMultifunctional Therapeutic Potential of Phytocomplexes and Natural Extracts for Antimicrobial","volume":"10","author":"Rahman","year":"2021","journal-title":"Properties,\u201c"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0270","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cell.2009.01.038","article-title":"A Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death","volume":"137","author":"Saijo","year":"2009","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0275","first-page":"798","article-title":"\u201cIn the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12","volume":"157","author":"Gazzinelli","year":"1996","journal-title":"IFN-gamma and TNF-alpha,\u201c"},{"issue":"7","key":"10.1016\/j.cyto.2022.155962_b0280","first-page":"3311","article-title":"\u201cIL-10 is required to prevent immune hyperactivity during infection with","volume":"158","author":"Hunter","year":"1997","journal-title":"Trypanosoma cruzi,\u201c"},{"key":"10.1016\/j.cyto.2022.155962_b0285","doi-asserted-by":"crossref","unstructured":"S. Magez, B. Stijlemans, G. Caljon, H.-P. Eugster, P. J. I. De Baetselier, and immunity, \u201cControl of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-\u03b1 induction,\u201d vol. 70, no. 3, pp. 1342-1351, 2002.","DOI":"10.1128\/IAI.70.3.1342-1351.2002"},{"key":"10.1016\/j.cyto.2022.155962_b0290","doi-asserted-by":"crossref","unstructured":"E. H. Wilson, U. Wille-Reece, F. Dzierszinski, and C. A. J. J. o. n. Hunter, \u201cA critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis,\u201d vol. 165, no. 1-2, pp. 63-74, 2005.","DOI":"10.1016\/j.jneuroim.2005.04.018"},{"key":"10.1016\/j.cyto.2022.155962_b0295","doi-asserted-by":"crossref","unstructured":"C. Li, L. A. Sanni, F. Omer, E. Riley, J. J. I. Langhorne, and immunity, \u201cPathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor \u03b2 antibodies,\u201d vol. 71, no. 9, pp. 4850-4856, 2003.","DOI":"10.1128\/IAI.71.9.4850-4856.2003"},{"key":"10.1016\/j.cyto.2022.155962_b0300","doi-asserted-by":"crossref","unstructured":"K. N. Couper et al., \u201cIL-10 from CD4+ CD25\u2212 Foxp3\u2212 CD127\u2212 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection,\u201d vol. 4, no. 2, p. e1000004, 2008.","DOI":"10.1371\/journal.ppat.1000004"},{"key":"10.1016\/j.cyto.2022.155962_b0305","doi-asserted-by":"crossref","unstructured":"A. Joss, M. Akdis, A. Faith, K. Blaser, and C. A. J. E. j. o. i. Akdis, \u201cIL\u201010 directly acts on T cells by specifically altering the CD28 co\u2010stimulation pathway,\u201d vol. 30, no. 6, pp. 1683-1690, 2000.","DOI":"10.1002\/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0.CO;2-A"},{"key":"10.1016\/j.cyto.2022.155962_b0310","doi-asserted-by":"crossref","unstructured":"K. F. Hoffmann, A. W. Cheever, and T. A. J. T. J. o. I. Wynn, \u201cIL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis,\u201d vol. 164, no. 12, pp. 6406-6416, 2000.","DOI":"10.4049\/jimmunol.164.12.6406"},{"key":"10.1016\/j.cyto.2022.155962_b0315","doi-asserted-by":"crossref","unstructured":"R. Hernandez\u2010Pando, D. Aguilar, M. L. G. Hernandez, H. Orozco, and G. J. E. j. o. i. Rook, \u201cPulmonary tuberculosis in BALB\/c mice with non\u2010functional IL\u20104 genes: changes in the inflammatory effects of TNF\u2010\u03b1 and in the regulation of fibrosis,\u201d vol. 34, no. 1, pp. 174-183, 2004.","DOI":"10.1002\/eji.200324253"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b0320","first-page":"585","volume":"16","author":"Wohlleben","year":"2004","journal-title":"Helminth infection modulates the development of allergen-induced airway inflammation"},{"key":"10.1016\/j.cyto.2022.155962_b0325","doi-asserted-by":"crossref","unstructured":"A. Yoshimura, Y. Wakabayashi, and T. J. T. j. o. b. Mori, \u201cCellular and molecular basis for the regulation of inflammation by TGF-\u03b2,\u201d vol. 147, no. 6, pp. 781-792, 2010.","DOI":"10.1093\/jb\/mvq043"},{"key":"10.1016\/j.cyto.2022.155962_b0330","doi-asserted-by":"crossref","unstructured":"L. B. Krupp, N. G. LaRocca, J. Muir-Nash, and A. D. Steinberg, \u201cThe fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus,\u201d (in eng), Arch Neurol, vol. 46, no. 10, pp. 1121-3, Oct 1989.","DOI":"10.1001\/archneur.1989.00520460115022"},{"issue":"9413","key":"10.1016\/j.cyto.2022.155962_b0335","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(04)15794-2","article-title":"Fatigue in neurological disorders","volume":"363","author":"Chaudhuri","year":"2004","journal-title":"The lancet"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0340","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1545968306298934","article-title":"Origin of fatigue in multiple sclerosis: review of the literature","volume":"22","author":"Kos","year":"2008","journal-title":"Neurorehabilitation and neural repair"},{"issue":"7","key":"10.1016\/j.cyto.2022.155962_b0345","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1017\/S1461145708008821","article-title":"A study using transcranial magnetic stimulation to investigate motor mechanisms in psychomotor retardation in depression","volume":"11","author":"Loo","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0350","first-page":"85","article-title":"Muscle performance, voluntary activation, twitch properties and perceived effort in normal subjects and patients with the chronic fatigue syndrome","volume":"114","author":"Lloyd","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.cyto.2022.155962_b0355","series-title":"\u201cSymptom management,\u201d Multiple Sclerosis: Diagnosis and Therapy","first-page":"213","author":"Stazzone","year":"2012"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0360","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11325-019-01921-4","article-title":"Excessive daytime sleepiness and fatigue in neurological disorders","volume":"24","author":"Maestri","year":"2020","journal-title":"Sleep and Breathing"},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b0365","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/jnnp-2017-316007","article-title":"Mechanisms of poststroke fatigue","volume":"89","author":"De Doncker","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b0370","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ana.410390405","article-title":"\u201cImpact of aerobic training on fitness and quality of life in multiple sclerosis,\u201d (in eng)","volume":"39","author":"Petajan","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cyto.2022.155962_b0375","doi-asserted-by":"crossref","unstructured":"A. L. Stewart, R. D. Hays, and J. E. Ware, Jr., \u201cThe MOS short-form general health survey. Reliability and validity in a patient population,\u201d (in eng), Med Care, vol. 26, no. 7, pp. 724-35, Jul 1988.","DOI":"10.1097\/00005650-198807000-00007"},{"key":"10.1016\/j.cyto.2022.155962_b0380","series-title":"Encyclopedia of Personality and Individual Differences","first-page":"1","article-title":"Profile of Mood States","author":"Searight","year":"2017"},{"key":"10.1016\/j.cyto.2022.155962_b0385","doi-asserted-by":"crossref","unstructured":"J. Friedman and H. Friedman, \u201cFatigue in Parkinson's disease,\u201d (in eng), Neurology, vol. 43, no. 10, pp. 2016-8, Oct 1993.","DOI":"10.1212\/WNL.43.10.2016"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0390","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1212\/WNL.45.2.306","article-title":"Muscular fatigue in Duchenne muscular dystrophy","volume":"45","author":"Sharma","year":"1995","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.cyto.2022.155962_b0395","first-page":"1450","article-title":"\u201cA study of fatigue in systemic lupus erythematosus,\u201d (in eng)","volume":"17","author":"Krupp","year":"1990","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.cyto.2022.155962_b0400","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archneur.1994.00540190089021","article-title":"\u201cCognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis,\u201d (in eng)","volume":"51","author":"Krupp","year":"1994","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0405","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/S0317167100048691","article-title":"\u201cThe impact of fatigue on patients with multiple sclerosis,\u201d (in eng)","volume":"21","author":"Fisk","year":"1994","journal-title":"Can J Neurol Sci"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b0410","first-page":"645","article-title":"\u201cFatigue in Brazilian cancer patients, caregivers, and nursing students: a psychometric validation study of the Piper Fatigue Scale-Revised,\u201d (in eng)","volume":"17","author":"Mota","year":"2009","journal-title":"Support Care Cancer"},{"issue":"7","key":"10.1016\/j.cyto.2022.155962_b0415","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0022-3999(93)90104-N","article-title":"\u201cThe measurement of fatigue: a new instrument,\u201d (in eng)","volume":"37","author":"Schwartz","year":"1993","journal-title":"J Psychosom Res"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b0420","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00019052-199612000-00011","article-title":"\u201cMechanisms and management of fatigue in progressive neurological disorders,\u201d (in eng)","volume":"9","author":"Krupp","year":"1996","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.cyto.2022.155962_b0425","doi-asserted-by":"crossref","unstructured":"T. G. J. I. J. o. P. M. Dinan, \u201cStudying brain receptor function: a neuroendocrine approach,\u201d vol. 10, no. 1, pp. 4-5, 1993.","DOI":"10.1017\/S0790966700013173"},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b0430","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1212\/WNL.46.3.632","article-title":"Fatigue in multiple sclerosis compared with chronic fatigue syndrome: a quantitative assessment","volume":"46","author":"Djaldetti","year":"1996","journal-title":"Neurology"},{"issue":"9\u201310","key":"10.1016\/j.cyto.2022.155962_b0435","first-page":"685","article-title":"\u201cThe problem of fatigue in neurological disorders,\u201d Wiadomosci Lekarskie (Warsaw","volume":"59","author":"Kumor","year":"1960","journal-title":"Poland"},{"key":"10.1016\/j.cyto.2022.155962_b0440","doi-asserted-by":"crossref","unstructured":"F. Paul and C. Veauthier, \u201cFatigue in multiple sclerosis: a diagnostic and therapeutic challenge,\u201d vol. 13, ed: Taylor & Francis, 2012, pp. 791-793.","DOI":"10.1517\/14656566.2012.667075"},{"issue":"9","key":"10.1016\/j.cyto.2022.155962_b0445","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.molmed.2021.06.002","article-title":"Insights from myalgic encephalomyelitis\/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome","volume":"27","author":"Komaroff","year":"2021","journal-title":"Trends Mol. Med."},{"issue":"17","key":"10.1016\/j.cyto.2022.155962_b0450","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1073\/pnas.92.17.7897","article-title":"\u201cInterleukin 1 beta up-regulates the expression of sulfoglucuronosyl paragloboside, a ligand for L-selectin, in brain microvascular endothelial cells,\u201d (in eng)","volume":"92","author":"Kanda","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b0455","first-page":"379","article-title":"\u201cMultiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a,\u201d (in eng)","volume":"5","author":"Mat\u00e0","year":"1999","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b0460","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/ana.410440621","article-title":"\u201cIncreased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis,\u201d (in eng)","volume":"44","author":"Sadatipour","year":"1998","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b0465","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1600-0404.1999.tb00387.x","article-title":"\u201cAnti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients,\u201d (in eng)","volume":"100","author":"Niebroj-Dobosz","year":"1999","journal-title":"Acta Neurol Scand"},{"issue":"24","key":"10.1016\/j.cyto.2022.155962_b0470","doi-asserted-by":"crossref","first-page":"11743","DOI":"10.1073\/pnas.90.24.11743","article-title":"IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayer","volume":"90","author":"Llin\u00e1s","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4978","key":"10.1016\/j.cyto.2022.155962_b0475","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.2218531","article-title":"\u201cNeurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides,\u201d (in eng)","volume":"250","author":"Yankner","year":"1990","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0480","doi-asserted-by":"crossref","first-page":"154","DOI":"10.7861\/clinmedicine.17-2-154","article-title":"\u201cThe latest national clinical guideline for stroke,\u201d (in eng)","volume":"17","author":"Rudd","year":"2017","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.cyto.2022.155962_b0485","doi-asserted-by":"crossref","unstructured":"L. Turner-Stokes, A. Pick, A. Nair, P. B. Disler, and D. T. Wade, \u201cMulti-disciplinary rehabilitation for acquired brain injury in adults of working age,\u201d (in eng), Cochrane Database Syst Rev, no. 12, p. Cd004170, Dec 22 2015.","DOI":"10.1002\/14651858.CD004170.pub3"},{"issue":"10","key":"10.1016\/j.cyto.2022.155962_b0490","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1532-5415.2008.01925.x","article-title":"\u201cComparison of fatigue levels in patients with stroke and patients with end-stage heart failure: application of the fatigue assessment scale,\u201d (in eng)","volume":"56","author":"Smith","year":"2008","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl 1","key":"10.1016\/j.cyto.2022.155962_b0495","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/clinids\/18.Supplement_1.S79","article-title":"\u201cMeasuring the functional impact of fatigue: initial validation of the fatigue impact scale,\u201d (in eng)","volume":"18","author":"Fisk","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b0500","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1191\/1352458502ms839oa","article-title":"\u201cFatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters,\u201d (in eng)","volume":"8","author":"Flachenecker","year":"2002","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b0505","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.parkreldis.2012.11.013","article-title":"\u201cValidation of the Modified Fatigue Impact Scale in Parkinson's disease,\u201d (in eng)","volume":"19","author":"Schiehser","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"10.1016\/j.cyto.2022.155962_b0510","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/jnnp.2008.151340","article-title":"\u201cRasch analysis of the Modified Fatigue Impact Scale (MFIS) in multiple sclerosis,\u201d (in eng)","volume":"81","author":"Mills","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b0515","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5014\/ajot.57.4.389","article-title":"Test\u2013retest reliability and convergent validity of the Fatigue Impact Scale for persons with multiple sclerosis","volume":"57","author":"Mathiowetz","year":"2003","journal-title":"The American journal of occupational therapy"},{"issue":"9","key":"10.1016\/j.cyto.2022.155962_b0520","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s11136-010-9704-7","article-title":"\u201cA novel approach to estimate the minimally important difference for the Fatigue Impact Scale in multiple sclerosis patients,\u201d (in eng)","volume":"19","author":"Rendas-Baum","year":"2010","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b0525","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/1352458506073528","article-title":"\u201cImpact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS),\u201d (in eng)","volume":"13","author":"Benito-Le\u00f3n","year":"2007","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b0530","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11136-005-4181-0","article-title":"\u201cImpact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS),\u201d (in eng)","volume":"15","author":"Martinez-Martin","year":"2006","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.cyto.2022.155962_b0535","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1161\/STROKEAHA.106.478941","article-title":"\u201cEvaluation of fatigue scales in stroke patients,\u201d (in eng)","volume":"38","author":"Mead","year":"2007","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0540","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0896-6273(00)80912-5","article-title":"Neural science: a century of progress and the mysteries that remain","volume":"25","author":"Albright","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.cyto.2022.155962_b0545","doi-asserted-by":"crossref","unstructured":"E. Cocco and P. J. E. n. Fadda, \u201cTreatment of multiple sclerosis fatigue with the synthetic psychoactive drug modafinil,\u201d vol. 347, p. 113906, 2022.","DOI":"10.1016\/j.expneurol.2021.113906"},{"key":"10.1016\/j.cyto.2022.155962_b0550","doi-asserted-by":"crossref","unstructured":"A. Chaudhuri and P. O. Behan, \u201cFatigue and basal ganglia,\u201d (in eng), J Neurol Sci, vol. 179, no. S 1-2, pp. 34-42, Oct 1 2000.","DOI":"10.1016\/S0022-510X(00)00411-1"},{"issue":"9413","key":"10.1016\/j.cyto.2022.155962_b0555","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(04)15794-2","article-title":"\u201cFatigue in neurological disorders,\u201d (in eng)","volume":"363","author":"Chaudhuri","year":"2004","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.cyto.2022.155962_b0560","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"\u201cThe chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group,\u201d (in eng)","volume":"121","author":"Fukuda","year":"1994","journal-title":"Ann Intern Med"},{"issue":"Pt 2","key":"10.1016\/j.cyto.2022.155962_b0565","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/brain\/120.2.299","article-title":"\u201cAn electrophysiological study of the mechanism of fatigue in multiple sclerosis,\u201d (in eng)","volume":"120","author":"Sheean","year":"1997","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b0570","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/135245859600100409","article-title":"\u201cMyogenic and central neurogenic factors in fatigue in multiple sclerosis,\u201d (in eng)","volume":"1","author":"Latash","year":"1996","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.cyto.2022.155962_b0575","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2165\/00023210-200216070-00002","article-title":"\u201cCognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management,\u201d (in eng)","volume":"16","author":"Bagert","year":"2002","journal-title":"CNS Drugs"},{"issue":"7","key":"10.1016\/j.cyto.2022.155962_b0580","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1212\/WNL.55.7.934","article-title":"\u201cFatigue and declines in cognitive functioning in multiple sclerosis,\u201d (in eng)","volume":"55","author":"Krupp","year":"2000","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.cyto.2022.155962_b0585","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/mus.1108","article-title":"Quadriceps muscle function and fatigue in women with Addison's disease","volume":"24","author":"Jakobi","year":"2001","journal-title":"Muscle & Nerve: Official Journal of the American Association of Electrodiagnostic Medicine"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0590","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/mds.10041","article-title":"Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease","volume":"17","author":"Isella","year":"2002","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"key":"10.1016\/j.cyto.2022.155962_b0595","doi-asserted-by":"crossref","unstructured":"J. Friedman and H. Friedman, \u201cFatigue in Parkinson's disease,\u201d Neurology, vol. 43, no. 10, pp. 2016-2016, 1993.","DOI":"10.1212\/WNL.43.10.2016"},{"issue":"8","key":"10.1016\/j.cyto.2022.155962_b0600","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.56.8.874","article-title":"Diurnal effects of motor activity and fatigue in Parkinson's disease","volume":"56","author":"Van Hilten","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b0605","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00002060-200007000-00005","article-title":"Word finding difficulty as a post-polio sequelae","volume":"79","author":"Bruno","year":"2000","journal-title":"Am. J. Phys. Med. Rehabil."},{"issue":"10","key":"10.1016\/j.cyto.2022.155962_b0610","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0003-9993(93)90062-F","article-title":"The neuropsychology of post-polio fatigue","volume":"74","author":"Bruno","year":"1993","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.cyto.2022.155962_b0615","first-page":"594","article-title":"Nocturnal generalized myoclonus as a post-polio sequelae","volume":"76","author":"Bruno","year":"1995","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.cyto.2022.155962_b0620","article-title":"Neurological rehabilitation","author":"Umphred","year":"2012","journal-title":"Elsevier Health Sciences"},{"issue":"7","key":"10.1016\/j.cyto.2022.155962_b0625","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/archneur.1996.00550070080014","article-title":"The measurement of fatigue in patients with multiple sclerosis: a multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects","volume":"53","author":"Vercoulen","year":"1996","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0630","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archneur.61.2.201","article-title":"The relationship between diffuse axonal damage and fatigue in multiple sclerosis","volume":"61","author":"Tartaglia","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cyto.2022.155962_b0635","series-title":"\u201cTreatment of fatigue in multiple sclerosis,\u201d Multiple sclerosis therapeutics","first-page":"467","author":"Krupp","year":"1999"},{"issue":"8","key":"10.1016\/j.cyto.2022.155962_b0640","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/sleep\/33.8.1061","article-title":"Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment","volume":"33","author":"Braley","year":"2010","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b0645","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s004150050382","article-title":"Fatigue and magnetic resonance imaging activity in multiple sclerosis","volume":"246","author":"Mainero","year":"1999","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0650","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/jnnp.2005.065805","article-title":"\u201cFatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?,\u201d (in eng)","volume":"77","author":"Heesen","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b0655","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/(SICI)1097-4547(19960815)45:4<322::AID-JNR1>3.0.CO;2-B","article-title":"Cytokines and the pathogenesis of multiple sclerosis","volume":"45","author":"Navikas","year":"1996","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0660","first-page":"3","article-title":"The neuroendocrinology of chronic fatigue syndrome: focus on the hypothalamic-pituitary-adrenal axis","volume":"14","author":"Scott","year":"1999","journal-title":"Funct. Neurol."},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0665","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00234-007-0304-3","article-title":"The basal ganglia: a substrate for fatigue in multiple sclerosis","volume":"50","author":"Tellez","year":"2008","journal-title":"Neuroradiology"},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b0670","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3174\/ajnr.A2412","article-title":"Voxelwise assessment of the regional distribution of damage in the brains of patients with multiple sclerosis and fatigue","volume":"32","author":"Riccitelli","year":"2011","journal-title":"American Journal of Neuroradiology"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b0675","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1006\/nimg.2001.0759","article-title":"Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement\u2014EEG evidence","volume":"13","author":"Leocani","year":"2001","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0680","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10072-008-0950-1","article-title":"Physiopathology of fatigue in multiple sclerosis","volume":"29","author":"Leocani","year":"2008","journal-title":"Neurological Sciences"},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b0685","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/mrm.21382","article-title":"Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy","volume":"58","author":"Blamire","year":"2007","journal-title":"Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine"},{"key":"10.1016\/j.cyto.2022.155962_b0690","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/CLEP.S10425","article-title":"Beyond fatigue: Assessing variables associated with sleep problems and use of sleep medications in multiple sclerosis","volume":"2","author":"Bamer","year":"2010","journal-title":"Clinical epidemiology"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0695","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/01.wnl.0000223316.53428.c9","article-title":"Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective","volume":"67","author":"Clemens","year":"2006","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.cyto.2022.155962_b0700","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1468-1331.2006.01499.x","article-title":"Fatigue and sleep disturbance in multiple sclerosis","volume":"13","author":"Kaynak","year":"2006","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b0705","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/jnnp-2014-308374","article-title":"Fatigue at time of CIS is an independent predictor of a subsequent diagnosis of multiple sclerosis","volume":"86","author":"Runia","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0710","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1352458508097466","article-title":"Longitudinal correlates of fatigue in multiple sclerosis","volume":"15","author":"E. Patrick, C. Christodoulou, L. Krupp, N. Y. S. M. Consortium","year":"2009","journal-title":"Multiple Sclerosis Journal"},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b0715","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1191\/1352458503ms904oa","article-title":"\u201cFatigue associated with multiple sclerosis: diagnosis, impact and management,\u201d (in eng)","volume":"9","author":"Bakshi","year":"2003","journal-title":"Mult Scler"},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b0720","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1212\/WNL.57.5.892","article-title":"\u201cCooling garment treatment in MS: clinical improvement and decrease in leukocyte NO production,\u201d (in eng)","volume":"57","author":"Beenakker","year":"2001","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b0725","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.plefa.2005.05.024","article-title":"\u201cLow fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients,\u201d (in eng)","volume":"73","author":"Weinstock-Guttman","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b0730","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s40263-016-0317-8","article-title":"Advances in the development of disease-modifying treatments for amyotrophic lateral sclerosis","volume":"30","author":"Moujalled","year":"2016","journal-title":"CNS drugs"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0735","first-page":"115","article-title":"Fatigue in postpolio syndrome","volume":"72","author":"Berlly","year":"1991","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b0740","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0745","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0960-8966(95)00013-5","article-title":"Post-polio muscle dysfunction 29th ENMC workshop 14\u201316 October 1994, Naarden, the Netherlands","volume":"6","author":"Borg","year":"1996","journal-title":"Neuromuscular disorders: NMD"},{"issue":"11","key":"10.1016\/j.cyto.2022.155962_b0750","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1428::AID-MUS10>3.0.CO;2-X","article-title":"An 8-year longitudinal study of muscle strength, muscle fiber size, and dynamic electromyogram in individuals with late polio","volume":"21","author":"Grimby","year":"1998","journal-title":"Muscle & Nerve: Official Journal of the American Association of Electrodiagnostic Medicine"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b0755","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mus.880040610","article-title":"Late changes in the motor unit after acute poliomyelitis","volume":"4","author":"Wiechers","year":"1981","journal-title":"Muscle & Nerve: Official Journal of the American Association of Electrodiagnostic Medicine"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b0760","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s004150050386","article-title":"\u201cPostpolio syndrome: poliovirus persistence is involved in the pathogenesis,\u201d (in eng)","volume":"246","author":"Julien","year":"1999","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0765","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1468-1331.2006.01552.x","article-title":"\u201cPost-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study,\u201d (in eng)","volume":"14","author":"Farbu","year":"2007","journal-title":"Eur J Neurol"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2022.155962_b0770","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jneuroim.2004.01.010","article-title":"\u201cPrior poliomyelitis-IVIg treatment reduces proinflammatory cytokine production,\u201d (in eng)","volume":"150","author":"Gonzalez","year":"2004","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b0775","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jprot.2008.11.014","article-title":"Identification of novel candidate protein biomarkers for the post-polio syndrome\u2014implications for diagnosis, neurodegeneration and neuroinflammation","volume":"71","author":"Gonzalez","year":"2009","journal-title":"J. Proteomics"},{"key":"10.1016\/j.cyto.2022.155962_b0780","unstructured":"R. A. Eshraghi and S. Heitmann, \u201cPost-Polio Syndrome: A Remnant of the Past,\u201d Proceedings of UCLA Healthcare, vol. 20, 2016."},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0785","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy","volume":"14","author":"Parkinson","year":"2002","journal-title":"The Journal of neuropsychiatry and clinical neurosciences"},{"key":"10.1016\/j.cyto.2022.155962_b0790","first-page":"7135","volume":"10","author":"Rahman","year":"2020","journal-title":"Emerging Promise of Nanoparticle-Based Treatment for Parkinson\u2019s disease"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0795","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/1531-8257(199903)14:2<237::AID-MDS1006>3.0.CO;2-X","article-title":"Fatigue in patients with Parkinson's disease","volume":"14","author":"Karlsen","year":"1999","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b0800","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jnnp.66.4.431","article-title":"Influence of clinical and demographic variables on quality of life in patients with Parkinson\u2019s disease","volume":"66","author":"Karlsen","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0805","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.parkreldis.2004.07.007","article-title":"The Parkinson fatigue scale","volume":"11","author":"Brown","year":"2005","journal-title":"Parkinsonism & related disorders"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0810","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mds.1042","article-title":"Exacerbated physical fatigue and mental fatigue in Parkinson's disease","volume":"16","author":"Lou","year":"2001","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b0815","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7861\/clinmedicine.16-4-365","article-title":"New concepts in the pathogenesis and presentation of Parkinson\u2019s disease","volume":"16","author":"Sauerbier","year":"2016","journal-title":"Clinical Medicine"},{"issue":"7","key":"10.1016\/j.cyto.2022.155962_b0820","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"The Lancet Neurology"},{"issue":"12","key":"10.1016\/j.cyto.2022.155962_b0825","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1212\/WNL.0000000000001953","article-title":"Greater motor progression in patients with Parkinson disease who carry LRRK2 risk variants","volume":"85","author":"Oosterveld","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0830","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/brain\/aws318","article-title":"Glucocerebrosidase mutations influence the natural history of Parkinson\u2019s disease in a community-based incident cohort","volume":"136","author":"Winder-Rhodes","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.cyto.2022.155962_b0835","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1016\/S1353-8020(11)70071-2","article-title":"Clinical management of pain and fatigue in Parkinson's disease","volume":"18","author":"Del Sorbo","year":"2012","journal-title":"Parkinsonism & related disorders"},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b0840","first-page":"275","article-title":"Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons","volume":"18","author":"Saez","year":"2004","journal-title":"In vivo"},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b0845","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/jnr.20996","article-title":"Production of nerve growth factor by \u03b2-amyloid-stimulated astrocytes induces p75NTR-dependent tau hyperphosphorylation in cultured hippocampal neurons","volume":"84","author":"S\u00e1ez","year":"2006","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0850","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcmed.2007.10.001","article-title":"Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease","volume":"39","author":"Rojo","year":"2008","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.cyto.2022.155962_b0855","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.mehy.2018.07.007","article-title":"The putative glymphatic signature of chronic fatigue syndrome: A new view on the disease pathogenesis and therapy","volume":"118","author":"Wostyn","year":"2018","journal-title":"Med. Hypotheses"},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b0860","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s12035-018-1188-4","article-title":"The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer\u2019s disease\u2014a critical review","volume":"56","author":"Sochocka","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0865","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-2011-101815","article-title":"Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology","volume":"25","author":"Morimoto","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0870","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-10-84","article-title":"Down\u2019s syndrome, neuroinflammation, and Alzheimer neuropathogenesis","volume":"10","author":"Wilcock","year":"2013","journal-title":"Journal of neuroinflammation"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-12-95","article-title":"TH1\/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab","volume":"12","author":"Oreja-Guevara","year":"2012","journal-title":"BMC neurology"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0880","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cercor\/1.1.103","article-title":"The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease","volume":"1","author":"Arnold","year":"1991","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.cyto.2022.155962_b0885","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fncel.2014.00112","article-title":"Neuroinflammation in the pathogenesis of Alzheimer\u2019s disease. A rational framework for the search of novel therapeutic approaches","volume":"8","author":"Morales","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-1-14","article-title":"Microglia and neuroinflammation: a pathological perspective","volume":"1","author":"Streit","year":"2004","journal-title":"Journal of neuroinflammation"},{"key":"10.1016\/j.cyto.2022.155962_b0895","first-page":"185","volume":"vol. 1:","author":"Gao","year":"2017","journal-title":"\u201cRoles of microglia in inflammation-mediated neurodegeneration: models, mechanisms, and therapeutic interventions for Parkinson's disease,\u201d in Advances in Neurotoxicology"},{"issue":"6645","key":"10.1016\/j.cyto.2022.155962_b0900","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/42257","article-title":"Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E","volume":"388","author":"Barger","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b0905","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0910","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1568010053586237","article-title":"Mechanisms of cell signaling and inflammation in Alzheimer's disease","volume":"4","author":"Ho","year":"2005","journal-title":"Current Drug Targets-Inflammation & Allergy"},{"issue":"12","key":"10.1016\/j.cyto.2022.155962_b0915","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1002\/jcp.22675","article-title":"Amyloid-\u03b2-induced reactive oxygen species production and priming are differentially regulated by ion channels in microglia","volume":"226","author":"Schilling","year":"2011","journal-title":"J. Cell. Physiol."},{"issue":"2\u20133","key":"10.1016\/j.cyto.2022.155962_b0920","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","article-title":"Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms","volume":"24","author":"Sastre","year":"2006","journal-title":"Int. J. Dev. Neurosci."},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0925","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0006-8993(03)02361-8","article-title":"Astrocytes accumulate A\u03b242 and give rise to astrocytic amyloid plaques in Alzheimer disease brains","volume":"971","author":"Nagele","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.cyto.2022.155962_b0930","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-662-05073-6_3","article-title":"Elucidating molecular mechanisms of Alzheimer\u2019s disease in microglial cultures","author":"Rogers","year":"2002","journal-title":"Neuroinflammation\u2014From Bench to Bedside"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b0935","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/glia.21087","article-title":"Astrocytes are GABAergic cells that modulate microglial activity","volume":"59","author":"Lee","year":"2011","journal-title":"Glia"},{"issue":"13","key":"10.1016\/j.cyto.2022.155962_b0940","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1177\/1352458513485655","article-title":"Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors","volume":"19","author":"Krause","year":"2013","journal-title":"Multiple Sclerosis Journal"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0945","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pmr.2005.01.014","article-title":"Multiple sclerosis-related fatigue","volume":"16","author":"MacAllister","year":"2005","journal-title":"Physical medicine and rehabilitation clinics of North America"},{"key":"10.1016\/j.cyto.2022.155962_b0950","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fneur.2014.00177","article-title":"Management of fatigue in persons with multiple sclerosis","volume":"5","author":"Khan","year":"2014","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0955","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/ijprm.ijprm_5_18","article-title":"Management of fatigue in neurological disorders: Implications for rehabilitation","volume":"1","author":"Khan","year":"2018","journal-title":"The Journal of the International Society of Physical and Rehabilitation Medicine"},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b0960","first-page":"273","volume":"145","author":"Li","year":"2022","journal-title":"Microglia and immunotherapy in Alzheimer\u2019s disease"},{"key":"10.1016\/j.cyto.2022.155962_b0965","first-page":"48","volume":"320","author":"Belkhelfa","year":"2018","journal-title":"The involvement of neuroinflammation and necroptosis in the hippocampus during vascular dementia"},{"key":"10.1016\/j.cyto.2022.155962_b0970","volume":"vol. 771","author":"Li","year":"2022","journal-title":"Exosomes isolated during dopaminergic neuron differentiation suppressed neuronal inflammation in a rodent model of Parkinson\u2019s disease"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0975","first-page":"222","article-title":"\u201cNeuroinflammation Is Associated with GFAP and sTREM2 Levels in","volume":"12","author":"Azzolini","year":"2022","journal-title":"Multiple Sclerosis,\u201c"},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b0980","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1086\/650486","article-title":"The diagnosis of viral respiratory disease in older adults","volume":"50","author":"Talbot","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0985","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/CMR.00045-07","article-title":"Respiratory viruses other than influenza virus: impact and therapeutic advances","volume":"21","author":"Nichols","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"issue":"10","key":"10.1016\/j.cyto.2022.155962_b0990","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/00006454-200010001-00002","article-title":"Transmission of viral respiratory infections in the home","volume":"19","author":"Goldmann","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b0995","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.chom.2013.07.010","article-title":"Salmonella require the fatty acid regulator PPAR\u03b4 for the establishment of a metabolic environment essential for long-term persistence","volume":"14","author":"Eisele","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b1000","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/14767050903184181","article-title":"Bronchiolitis-associated encephalopathy in critically-ill infants: an underestimated complication?","volume":"23","author":"Antonucci","year":"2010","journal-title":"The Journal of Maternal-Fetal & Neonatal Medicine"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b1005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10152-011-0262-3","article-title":"Embryonic development of the sea bass Dicentrarchus labrax","volume":"66","author":"Cucchi","year":"2012","journal-title":"Helgol. Mar. Res."},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b1010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/00207454.2016.1138951","article-title":"Examination of neurological prognostic markers in patients with respiratory syncytial virus-associated encephalopathy","volume":"127","author":"Morichi","year":"2017","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.cyto.2022.155962_b1015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ebcr.2017.01.003","article-title":"Influenza-associated seizures in healthy adults: report of 3 cases","volume":"8","author":"Ruisanchez-Nieva","year":"2017","journal-title":"Epilepsy & behavior case reports"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b1020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000487398","article-title":"Focal encephalitis, meningitis, and acute respiratory distress syndrome associated with influenza A infection","volume":"27","author":"Liang","year":"2018","journal-title":"Medical Principles and Practice"},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b1025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7883\/yoken.JJID.2007.328","article-title":"A fatal case of encephalopathy possibly associated with human metapneumovirus infection","volume":"60","author":"Hata","year":"2007","journal-title":"Japanese journal of infectious diseases"},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b1030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archneurol.2011.1094","article-title":"Human metapneumovirus in the cerebrospinal fluid of a patient with acute encephalitis","volume":"69","author":"Fern\u00e1ndez","year":"2012","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b1035","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3201\/eid1002.030638","article-title":"Possible central nervous system infection by SARS coronavirus","volume":"10","author":"Lau","year":"2004","journal-title":"Emerg. Infect. Dis."},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b1040","doi-asserted-by":"crossref","first-page":"e1360","DOI":"10.1542\/peds.2006-0907","article-title":"Atopic disposition, wheezing, and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: a nested case-control study","volume":"118","author":"Stensballe","year":"2006","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b1045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2012.03.019","article-title":"Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets","volume":"65","author":"Denizot","year":"2012","journal-title":"J. Infect."},{"issue":"12","key":"10.1016\/j.cyto.2022.155962_b1050","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1086\/509330","article-title":"Beyond viruses: clinical profiles and etiologies associated with encephalitis","volume":"43","author":"Glaser","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b1055","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nri2971","article-title":"Illuminating viral infections in the nervous system","volume":"11","author":"McGavern","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b1060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrn3029","article-title":"Microbes' roadmap to neurons","volume":"12","author":"Kristensson","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cyto.2022.155962_b1065","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8562805","article-title":"Neuroinvasion and inflammation in viral central nervous system infections","volume":"2016","author":"Dahm","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cyto.2022.155962_b1070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coviro.2014.12.009","article-title":"Viral diseases of the central nervous system","volume":"11","author":"Swanson","year":"2015","journal-title":"Current opinion in virology"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b1075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ana.24304","article-title":"Targeting mi R-155 restores abnormal microglia and attenuates disease in SOD 1 mice","volume":"77","author":"Butovsky","year":"2015","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.cyto.2022.155962_b1080","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.3390\/v6072796","article-title":"Mechanism of West Nile virus neuroinvasion: a critical appraisal","volume":"6","author":"Suen","year":"2014","journal-title":"Viruses"},{"issue":"Pt 6","key":"10.1016\/j.cyto.2022.155962_b1085","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1099\/vir.0.040899-0","article-title":"West Nile virus-induced disruption of the blood\u2013brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases","volume":"93","author":"Roe","year":"2012","journal-title":"The Journal of general virology"},{"issue":"8","key":"10.1016\/j.cyto.2022.155962_b1090","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s00705-016-2880-1","article-title":"Taxonomy of the order Mononegavirales: update 2016","volume":"161","author":"Afonso","year":"2016","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b1095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-10-305","article-title":"Altered cardiac rhythm in infants with bronchiolitis and respiratory syncytial virus infection","volume":"10","author":"Esposito","year":"2010","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cyto.2022.155962_b1100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1651-2227.2003.tb00646.x","article-title":"Intestinal microflora in early infancy: composition and development","volume":"92","author":"Fanaro","year":"2003","journal-title":"Acta Paediatr."},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b1105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.11613\/BM.2013.014","article-title":"Hepatitis during respiratory syncytial virus infection\u2013a case report","volume":"23","author":"Kristi\u0107 Kirin","year":"2013","journal-title":"Biochemia medica"},{"issue":"15","key":"10.1016\/j.cyto.2022.155962_b1110","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM200110113451515","article-title":"Respiratory syncytial virus","volume":"345","author":"Ng","year":"2001","journal-title":"The New England journal of medicine"},{"issue":"10","key":"10.1016\/j.cyto.2022.155962_b1115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/archneur.1975.00490520023002","article-title":"Treatment of cataplexy with clomipramine","volume":"32","author":"Shapiro","year":"1975","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b1120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.braindev.2006.06.008","article-title":"Elevated CSF IL-6 in a patient with respiratory syncytial virus encephalopathy","volume":"29","author":"Otake","year":"2007","journal-title":"Brain and Development"},{"key":"10.1016\/j.cyto.2022.155962_b1125","doi-asserted-by":"crossref","unstructured":"C. D. Patel, S. A. Taylor, J. Mehrbach, S. Awasthi, H. M. Friedman, and D. A. Leib, \u201cTrivalent glycoprotein subunit vaccine prevents neonatal herpes simplex virus mortality and morbidity,\u201d Journal of virology, vol. 94, no. 11, 2020.","DOI":"10.1128\/JVI.02163-19"},{"issue":"8","key":"10.1016\/j.cyto.2022.155962_b1130","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1080\/21505594.2017.1365216","article-title":"Novel Influenza D virus: Epidemiology, pathology, evolution and biological characteristics","volume":"8","author":"Su","year":"2017","journal-title":"Virulence"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b1135","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3201\/eid2304.161317","article-title":"Neurologic complications of influenza B virus infection in adults, Romania","volume":"23","author":"Popescu","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.cyto.2022.155962_b1140","doi-asserted-by":"crossref","unstructured":"K. Bohmwald Prieto, N. M. Galvez, and M. Rios Raggio, \u201cNeurologic alterations due to respiratory virus infections,\u201d 2018.","DOI":"10.3389\/fncel.2018.00386"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b1145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124047","article-title":"Induction of microglia activation after infection with the non-neurotropic A\/CA\/04\/2009 H1N1 influenza virus","volume":"10","author":"Sadasivan","year":"2015","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b1150","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/89098","article-title":"A newly discovered human pneumovirus isolated from young children with respiratory tract disease","volume":"7","author":"Van den Hoogen","year":"2001","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b1155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/viro.2001.1355","article-title":"Analysis of the genomic sequence of a human metapneumovirus (hMPV)","volume":"295","author":"van deHoogen","year":"2002","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b1160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0002-9343(85)90361-4","article-title":"Epidemiology of community-acquired respiratory tract infections in adults: incidence, etiology, and impact","volume":"78","author":"Garibaldi","year":"1985","journal-title":"The American journal of medicine"},{"issue":"11","key":"10.1016\/j.cyto.2022.155962_b1165","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1086\/340518","article-title":"Characterization of human metapneumoviruses isolated from patients in North America","volume":"185","author":"Peret","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.cyto.2022.155962_b1170","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3201\/eid0809.020084","article-title":"Human metapneumovirus as a cause of community-acquired respiratory illness","volume":"8","author":"Stockton","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.cyto.2022.155962_b1175","unstructured":"Q. Li et al., \u201cEarly transmission dynamics in Wuhan, China, of novel coronavirus\u2013infected pneumonia,\u201d New England journal of medicine, 2020."},{"key":"10.1016\/j.cyto.2022.155962_b1180","doi-asserted-by":"crossref","unstructured":"P. Serrano-Castro et al., \u201cImpact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?,\u201d Neurolog\u00eda (English Edition), 2020.","DOI":"10.1016\/j.nrleng.2020.04.002"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b1185","first-page":"245","volume":"35","author":"Serrano-Castro","year":"2020","journal-title":"Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?"},{"issue":"9380","key":"10.1016\/j.cyto.2022.155962_b1190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(03)13967-0","article-title":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome","volume":"362","author":"Kuiken","year":"2003","journal-title":"The Lancet"},{"issue":"12","key":"10.1016\/j.cyto.2022.155962_b1195","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1373\/clinchem.2003.025437","article-title":"Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome","volume":"49","author":"Hung","year":"2003","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b1200","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s15010-015-0720-y","article-title":"Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)","volume":"43","author":"Arabi","year":"2015","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b1205","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.113.1.e73","article-title":"Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis","volume":"113","author":"Yeh","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.cyto.2022.155962_b1210","doi-asserted-by":"crossref","unstructured":"A. Filatov, P. Sharma, F. Hindi, and P. S. Espinosa, \u201cNeurological complications of coronavirus disease (COVID-19): encephalopathy,\u201d Cureus, vol. 12, no. 3, 2020.","DOI":"10.7759\/cureus.7352"},{"issue":"10","key":"10.1016\/j.cyto.2022.155962_b1215","first-page":"1016","article-title":"Sars-Cov-2: underestimated damage to nervous system","volume":"101642","author":"Zhou","year":"2020","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b1220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146288","article-title":"Characteristic cytokine and chemokine profiles in encephalitis of infectious, immune-mediated, and unknown aetiology","volume":"11","author":"Michael","year":"2016","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b1225","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA neurology"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b1230","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jmv.25728","article-title":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b1235","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/jamaneurol.2020.1065","article-title":"The spectrum of neurologic disease in the severe acute respiratory syndrome coronavirus 2 pandemic infection: neurologists move to the frontlines","volume":"77","author":"Pleasure","year":"2020","journal-title":"JAMA neurology"},{"key":"10.1016\/j.cyto.2022.155962_b1240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2020.04.027","article-title":"Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms","author":"Troyer","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b1245","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b1250","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/jir.2014.0227","article-title":"Disease-promoting effects of type I interferons in viral, bacterial, and coinfections","volume":"35","author":"Davidson","year":"2015","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.cyto.2022.155962_b1255","doi-asserted-by":"crossref","unstructured":"B. Hu, S. Huang, and L. J. J. o. m. v. Yin, \u201cThe cytokine storm and COVID\u201019,\u201d vol. 93, no. 1, pp. 250-256, 2021.","DOI":"10.1002\/jmv.26232"},{"key":"10.1016\/j.cyto.2022.155962_b1260","series-title":"The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement","author":"Hotez","year":"2020"},{"key":"10.1016\/j.cyto.2022.155962_b1265","doi-asserted-by":"crossref","unstructured":"S. F. Pedersen and Y.-C. Ho, \u201cSARS-CoV-2: a storm is raging,\u201d The Journal of clinical investigation, vol. 130, no. 5, 2020.","DOI":"10.1172\/JCI137647"},{"issue":"3","key":"10.1016\/j.cyto.2022.155962_b1270","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jmii.2020.03.005","article-title":"TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib","volume":"53","author":"Wu","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.cyto.2022.155962_b1275","doi-asserted-by":"crossref","unstructured":"S. A. Vardhana and J. D. Wolchok, \u201cThe many faces of the anti-COVID immune response,\u201d Journal of Experimental Medicine, vol. 217, no. 6, 2020.","DOI":"10.1084\/jem.20200678"},{"key":"10.1016\/j.cyto.2022.155962_b1280","doi-asserted-by":"crossref","unstructured":"B. Debuc and D. M. Smadja, \u201cIs COVID-19 a new hematologic disease?,\u201d Stem cell reviews and reports, pp. 1-5, 2020.","DOI":"10.1007\/s12015-020-09987-4"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b1285","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/cei.12881","article-title":"Innate immune responses in the ageing lung","volume":"187","author":"Boe","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b1290","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2022.155962_b1295","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b1300","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4049\/jimmunol.2000413","article-title":"COVID-19 as an acute inflammatory disease","volume":"205","author":"Manjili","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2022.155962_b1305","doi-asserted-by":"crossref","unstructured":"S. Felsenstein, J. A. Herbert, P. S. McNamara, and C. M. Hedrich, \u201cCOVID-19: Immunology and treatment options,\u201d Clinical Immunology, p. 108448, 2020.","DOI":"10.1016\/j.clim.2020.108448"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2022.155962_b1310","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(02)03640-2","article-title":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme","volume":"532","author":"Harmer","year":"2002","journal-title":"FEBS Lett."},{"issue":"15","key":"10.1016\/j.cyto.2022.155962_b1315","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1128\/JVI.00737-08","article-title":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2","volume":"82","author":"Netland","year":"2008","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b1320","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-3083.1991.tb02548.x","article-title":"Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes","volume":"33","author":"Mattern","year":"1991","journal-title":"Scand. J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b1325","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1078\/0171-9335-00302","article-title":"The multifunctional or moonlighting protein CD26\/DPPIV","volume":"82","author":"Boonacker","year":"2003","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.cyto.2022.155962_b1330","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuint.2018.01.005","article-title":"Dipeptidyl peptidase IV, which probably plays important roles in Alzheimer disease (AD) pathology, is upregulated in AD brain neurons and associates with amyloid plaques","volume":"114","author":"Bernstein","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.cyto.2022.155962_b1335","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fncel.2018.00386","article-title":"Neurologic alterations due to respiratory virus infections","volume":"12","author":"Bohmwald","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"10","key":"10.1016\/j.cyto.2022.155962_b1340","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.cyto.2022.155962_b1345","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1007\/s12035-018-0983-2","article-title":"Neuroinflammation, gut microbiome, and Alzheimer\u2019s disease","volume":"55","author":"Lin","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cyto.2022.155962_b1350","doi-asserted-by":"crossref","unstructured":"S. K. Biswas, \u201cDoes the interdependence between oxidative stress and inflammation explain the antioxidant paradox?,\u201d Oxidative medicine and cellular longevity, vol. 2016, 2016.","DOI":"10.1155\/2016\/5698931"},{"issue":"18","key":"10.1016\/j.cyto.2022.155962_b1355","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.3390\/ijms20184472","article-title":"Inflammaging and oxidative stress in human diseases: from molecular mechanisms to novel treatments","volume":"20","author":"Zuo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2022.155962_b1360","first-page":"233","volume":"27","author":"Rahman","year":"2021","journal-title":"Role of phenolic compounds in human disease: current knowledge and future prospects"},{"key":"10.1016\/j.cyto.2022.155962_b1365","first-page":"12638","volume":"22","author":"Islam","year":"2021","journal-title":"Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19"},{"issue":"9","key":"10.1016\/j.cyto.2022.155962_b1370","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2018.1264","article-title":"Current concepts in diagnosis and treatment of functional neurological disorders","volume":"75","author":"Espay","year":"2018","journal-title":"JAMA neurology"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b1375","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.NPT.0000260571.77487.14","article-title":"Physical therapy management for conversion disorder: case series","volume":"31","author":"Ness","year":"2007","journal-title":"Journal of Neurologic Physical Therapy"},{"key":"10.1016\/j.cyto.2022.155962_b1380","doi-asserted-by":"crossref","unstructured":"T. Wijeratne, S. Gillard Crewther, C. Sales, and L. J. F. i. n. Karimi, \u201cCOVID-19 pathophysiology predicts that ischemic stroke occurrence is an expectation, not an exception\u2014A systematic review,\u201d vol. 11, p. 1759, 2021.","DOI":"10.3389\/fneur.2020.607221"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b1385","first-page":"167","article-title":"Distinctive features of short-term psychodynamic-interpersonal psychotherapy: A review of the comparative psychotherapy process literature","volume":"7","author":"Blagys","year":"2000","journal-title":"Clinical psychology: Science and practice"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b1390","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/00048679609065021","article-title":"Janet and Freud: Revealing the roots of dynamic psychiatry","volume":"30","author":"Brown","year":"1996","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.cyto.2022.155962_b1395","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp-2019-321926","article-title":"Systematic review of psychotherapy for adults with functional neurological disorder","volume":"92","author":"Gutkin","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.cyto.2022.155962_b1400","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1176\/appi.ajp.2017.17040450","article-title":"Treatment for patients with a functional neurological disorder (conversion disorder): An integrated approach","volume":"175","author":"O\u2019Neal","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.cyto.2022.155962_b1405","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","article-title":"Neuroinflammation pathways: a general review","volume":"127","author":"Shabab","year":"2017","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.cyto.2022.155962_b1410","series-title":"\u201cFunctional Movement Disorders,\u201d in Movement Disorder Emergencies","first-page":"353","author":"Stephen","year":"2022"},{"issue":"6","key":"10.1016\/j.cyto.2022.155962_b1415","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1212\/WNL.0b013e318228c0c7","article-title":"Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial","volume":"77","author":"Sharpe","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.cyto.2022.155962_b1420","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/glia.10154","article-title":"Microglia as neuroprotective, immunocompetent cells of the CNS","volume":"40","author":"Streit","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.cyto.2022.155962_b1425","doi-asserted-by":"crossref","unstructured":"A. Chaudhuri and P. O. J. T. l. Behan, \u201cFatigue in neurological disorders,\u201d vol. 363, no. 9413, pp. 978-988, 2004.","DOI":"10.1016\/S0140-6736(04)15794-2"},{"key":"10.1016\/j.cyto.2022.155962_b1430","doi-asserted-by":"crossref","first-page":"079","DOI":"10.29328\/journal.ijcv.1001020","article-title":"Inhaled statins to combat COVID-19\u2013prophylactic and treatment approach","volume":"4","author":"Iyer","year":"2020","journal-title":"Int J Clin Virol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466622001715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466622001715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:48:01Z","timestamp":1760910481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466622001715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":286,"alternative-id":["S1043466622001715"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2022.155962","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the management approaches of cytokines including viral infection and neuroinflammation for neurological disorders","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2022.155962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155962"}}